Address
Email address
Phone number
https://sydameapteek.eeKõik ravimid Südameapteegi e-apteegistSüdameapteegi e-apteek: telli mugavalt ravimid, toidulisandid, vitamiinid ja apteegikosmeetika pakiautomaati, apteeki või koju. Tarne alates 0 eurot.
Name
Pharma Holding OÜ
Registry code
12009590
VAT number
EE101511045
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.10.2010 (14)
Financial year
01.01-31.12
Capital
4 557.00 €
Activity
77401 - Leasing of intellectual property and similar products, except copyrighted works
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pharma Holding OÜ 12009590 | 17% - 797.00 EUR | - | - | |
| SA Holding OÜ 16508462 | 83% - 3 760.00 EUR | - | - | |
| Eveli Adrikorn
| - | Board member | - | |
| Omanikukonto: RISTO LAUR
| - | Board member | - | |
| Tarmo Laanetu
| - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pharma Holding OÜ 12009590 | 17% - 797.00 EUR | - | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 5 664 182.57 € | 387 559.55 € | 189 806.22 € | 26 |
| 2024 Q3 | 4 821 624.49 € | 348 014.3 € | 187 099.91 € | 30 |
| 2024 Q2 | 5 121 996.06 € | 365 778.26 € | 229 046.27 € | 29 |
| 2024 Q1 | 4 294 609.5 € | 102 302.47 € | 202 823.55 € | 29 |
| 2023 Q4 | 5 250 238.42 € | 355 366.05 € | 211 878.91 € | 31 |
| 2023 Q3 | 4 806 491.07 € | 351 506.02 € | 211 478.69 € | 31 |
| 2023 Q2 | 5 188 444.37 € | 370 488.75 € | 241 593.26 € | 31 |
| 2023 Q1 | 4 798 388.56 € | 345 998.82 € | 254 223.56 € | 33 |
| 2022 Q4 | 5 215 585.94 € | 337 269.65 € | 189 200.77 € | 34 |
| 2022 Q3 | 4 637 659.52 € | 301 027.05 € | 178 068.32 € | 30 |
| 2022 Q2 | 4 647 774.54 € | 340 113.46 € | 241 170.9 € | 30 |
| 2022 Q1 | 4 606 574.92 € | 271 789.23 € | 177 021.21 € | 32 |
| 2021 Q4 | 4 691 797.33 € | 231 999.32 € | 173 364.15 € | 30 |
| 2021 Q3 | 3 988 040.05 € | 234 873.67 € | 165 823.82 € | 31 |
| 2021 Q2 | 4 051 383.47 € | 316 815.44 € | 202 690.14 € | 29 |
| 2021 Q1 | 3 908 751.78 € | 238 826.96 € | 158 684.34 € | 31 |
| 2020 Q4 | 3 527 437.51 € | 189 416.85 € | 144 722.11 € | 31 |
| 2020 Q3 | 2 215 009.28 € | 145 885.23 € | 151 926.27 € | 32 |
| 2020 Q2 | 1 818 258.92 € | 177 966.27 € | 187 436.22 € | 29 |
| 2020 Q1 | 2 124 440.84 € | 164 747.95 € | 165 111.45 € | 30 |
